CDIO
Cardio Diagnostics Holdings IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$5.30M
P/E Ratio
—
EPS
$-3.71
Beta
2.66
52W High
$14.46
52W Low
$0.97
50-Day MA
$2.84
200-Day MA
$3.22
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Cardio Diagnostics Holdings Inc
Cardio Diagnostics Holdings Inc (CDIO) is an innovative biotechnology firm dedicated to transforming cardiovascular health through advanced diagnostic solutions. By utilizing state-of-the-art technologies, CDIO empowers healthcare providers with essential tools for the precise assessment and management of cardiovascular diseases, significantly improving patient outcomes. The company’s strong focus on personalized medicine positions it for robust growth and makes it an attractive prospect for institutional investors looking to capitalize on the advancements in the rapidly evolving healthcare landscape.
Fundamentals
| Revenue (TTM) | 14,820 |
| Gross Profit (TTM) | 14,820 |
| EBITDA | $-6.09M |
| Operating Margin | -41160.00% |
| Return on Equity | -78.60% |
| Return on Assets | -44.10% |
| Revenue/Share (TTM) | $0.01 |
| Book Value | $3.82 |
| Price-to-Book | 0.76 |
| Price-to-Sales (TTM) | 357.33 |
| EV/Revenue | 61.52 |
| EV/EBITDA | -22.48 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -21.20% |
| Shares Outstanding | $2.96M |
| Float | $2.83M |
| % Insiders | 8.31% |
| % Institutions | 4.38% |
Data last updated: 5/1/2026